Published Online: November 17, 2014. doi:10.1001/jamainternmed.2014.6288.
Study concept and design: All authors.
Acquisition, analysis, or interpretation of data: Miedema, Lopez, Blaha, Virani, Folsom.
Drafting of the manuscript: Miedema.
Critical revision of the manuscript for important intellectual content: Lopez, Blaha, Virani, Coresh, Ballantyne, Folsom.
Statistical analysis: Miedema, Lopez.
Obtained funding: Coresh, Folsom.
Administrative, technical, or material support: Virani.
Study supervision: Folsom.
Conflict of Interest Disclosures: Dr Ballantyne has received institutional grant support from Abbott Diagnostics, Amarin, Amgen, Eli Lilly, Esperion, GlaxoSmithKline, Genentech, Merck, Novartis, Pfizer, Regeneron, Roche, Roche Diagnostic, Sanofi-Synthelabo, the National Institutes of Health, and the American Heart Association and has served as a consultant to Abbott Diagnostics, Aegerion, Amarin, Amgen, Arena, Cerenis, Esperion, Genentech, Genzyme, Kowa, Merck, Novartis, Pfizer, Resverlogix, Regeneron, Roche, and Sanofi-Synthelabo. No other disclosures were reported.